Instillation of liposomes vs dimethyl sulphoxide or pentosan polysulphate for reducing bladder hyperactivity

BJU International

Volumn 104, Issue 11, 2009, Pages 1689-1692

  Tyagi, Pradeep ^a   Hsieh, Vincent C ^b   Yoshimura, Naoki ^c   Kaufman, Jonathan ^d   Chancellor, Michael B ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d Lipella Pharmaceuticals Inc   (United States)

Author keywords

Bladder; Health; Interstitial cystitis; Liposome; Overactive; Women

Indexed keywords

DIMETHYL SULFOXIDE; LIPOSOME; PENTOSAN POLYSULFATE; POTASSIUM CHLORIDE; PROTAMINE SULFATE; SODIUM CHLORIDE; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CONTRACTION; BLADDER PRESSURE; CONTROLLED STUDY; CYSTOMETRY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG INSTILLATION; FEMALE; MICTURITION REFLEX; NONHUMAN; OVERACTIVE BLADDER; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVESICAL; ANIMALS; CYSTITIS, INTERSTITIAL; DIMETHYL SULFOXIDE; DRUG CARRIERS; FEMALE; LIPOSOMES; PENTOSAN SULFURIC POLYESTER; PROTAMINES; RATS; RATS, SPRAGUE-DAWLEY; URINARY BLADDER, OVERACTIVE;

EID: 70449344600     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08673.x     Document Type: Article

References (17)

1. Parsons CL, Lilly JD, Stein P. Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol 1991 145 : 732 735
2. Parsons CL, Stein PC, Bidair M, Lebow D. Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. Neurourol Urodyn 1994 13 : 515 520
3. Hohlbrugger G. The vesical blood-urine barrier: a relevant and dynamic interface between renal function and nervous bladder control. J Urol 1995 154 : 6 15
4. Parsons CL, Housley T, Schmidt JD, Lebow D. Treatment of interstitial cystitis with intravesical heparin. Br J Urol 1994 73 : 504 507
5. Parsons CL, Schmidt JD, Pollen JJ. Successful treatment of interstitial cystitis with sodium pentosanpolysulfate. J Urol 1983 130 : 51 7
6. Ghoniem GM, McBride D, Sood OP, Lewis V. Clinical experience with multiagent intravesical therapy in interstitial cystitis patients unresponsive to single-agent therapy. World J Urol 1993 11 : 178 180
7. Nordling J. Interstitial cystitis: how should we diagnose it and treat it in 2004? Curr Opin Urol 2004 14 : 323 327
8. Fraser MO, Chuang YC, Tyagi P et al. Intravesical liposome administration - a novel treatment for hyperactive bladder in the rat. Urology 2003 61 : 656 663
9. Metselaar JM, Storm G. Liposomes in the treatment of inflammatory disorders. Expert Opin Drug Deliv 2005 2 : 465 464
10. Chuang YC, Chancellor MB, Seki S, Yoshimura N, Tyagi P, Huang L. Intravesical protamine sulfate and potassium chloride as a model for bladder hyperactivity. Urology 2003 61 : 664 670
11. Birder LA, Kanai AJ, de Groat WC. DMSO effect on bladder afferent neurons and nitric oxide release. J Urol 1997 158 : 1989 1994
12. Rajasekaran M, Stein P, Parsons CL. Toxic factors in human urine that injure urothelium. Int J Urol 2006 13 : 409 412
13. Lilly JD, Parsons CL. Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surg Gynecol Obstet 1990 171 : 493 496
14. Parsons CL, Greenberger M, Gabal L, Bidair M, Barme G. The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol 1998 159 : 1862 1866
15. Bade JJ, Laseur M, Nieuwenburg A, van der Weele LT, Mensink HJ. A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis. Br J Urol 1997 79 : 168 171
16. Melchior D, Packer CS, Johnson TC, Kaefer M. Dimethyl sulfoxide: does it change the functional properties of the bladder wall? J Urol 2003 170 : 253 8
17. Schafer-Korting M, Korting HC, Braun-Falco O. Liposome preparations: a step forward in topical drug therapy for skin disease? A review. J Am Acad Dermatol 1989 21 : 1271 1275